A CRISPR-Cas9 screen shows the combination efficacy of lenvatinib plus epidermal growth factor receptor inhibitors for treatment of liver cancer

CANCER BIOLOGY & MEDICINE

CHINA ANTI-CANCER ASSOC

1. National Natural Science Foundation of China [81920108025]
2. Shanghai Municipal Science and Technology Project [20JC1411100]
3. 111 Project [B21024]